[How to improve the results of treatment of myelodysplastic syndromes in the studies of Polish pediatric leukemia/lymphoma group].
Fourty two children with myelodysplastic syndrome (MDS) treated in seven centres of The Polish Paediatric Leukaemia/Lymphoma Study Group in period 1975-1998 were included in the study. In 16 children RAEB-T, in 3 CMML, in 10 RA and in 13 RAEB were diagnosed. BMT is the best therapy for children with MDS. For children, who have not a donor for BMT, Roacutan therapy seems to be the most effective.
Chybicka
A
A
Kliniki Hematologii i Chorób Rozrostowych Dzieci Akademii Medycznej we Wrocławiu.
Kołecki
P
P
Pietras
W
W
Wójcik
D
D
Turkiewicz
D
D
Armata
J
J
Eliasińska
A
A
Kowalczyk
J
J
Jackowska
T
T
Klus
K
K
Matysiak
M
M
Krauze
A
A
Stefańska
K
K
Rokicka-Milewska
R
R
Wiśniewska-Slusarz
H
H
D000293:Adolescent; D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
D000970:Antineoplastic Agents